These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3677678)

  • 41. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
    Norris LA; Bonnar J
    Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolic changes during treatment with two different progestogens.
    Refn H; Kjaer A; Lebech AM; Borggaard B; Schierup L; Bremmelgaard A
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):374-7. PubMed ID: 2115298
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of three types of combined O.C. pills on blood coagulation, fibrinolysis and platelet function.
    Prasad RN; Koh S; Ratnam SS
    Contraception; 1989 Apr; 39(4):369-83. PubMed ID: 2524360
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence that smoking alters prostacyclin formation and platelet aggregation in women who use oral contraceptives.
    Mileikowsky GN; Nadler JL; Huey F; Francis R; Roy S
    Am J Obstet Gynecol; 1988 Dec; 159(6):1547-52. PubMed ID: 3061301
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma high-density-lipoprotein cholesterol levels during long-term use of an oral contraceptive in Nigerian women.
    Taylor GO; Agbedana EO; Ojo OA
    Br J Obstet Gynaecol; 1982 Nov; 89(11):944-7. PubMed ID: 7171504
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral contraceptives and the cobalamin (vitamin B12) metabolism.
    Hjelt K; Brynskov J; Hippe E; Lundström P; Munck O
    Acta Obstet Gynecol Scand; 1985; 64(1):59-63. PubMed ID: 3976378
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of age, sex and the oral contraceptive on the platelet membrane fibrinogen binding site (glycoprotein IIb/IIIa).
    Cahill M; Mistry R; Chapman C; Wood JK; Barnett DB
    Br J Clin Pharmacol; 1992 Jan; 33(1):11-5. PubMed ID: 1540480
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of oral contraceptives on mononuclear cell cholesteryl ester hydrolase activity.
    Hagemenas FC; Yatsu FM; Manaugh LC
    Lipids; 1980 Jan; 15(1):39-44. PubMed ID: 7360009
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.
    Falsetti L; Pasinetti E
    Acta Obstet Gynecol Scand; 1995 Jan; 74(1):56-60. PubMed ID: 7856434
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of oral contraceptives on serum lipid profiles of women runners.
    Gray DP; Harding E; Dale E
    Fertil Steril; 1983 Apr; 39(4):510-4. PubMed ID: 6832406
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of triphasic and biphasic oral contraceptive preparations on HDL-cholesterol and LDL-cholesterol in young women.
    Percival-Smith RK; Morrison BJ; Sizto R; Abercrombie B
    Contraception; 1987 Feb; 35(2):179-87. PubMed ID: 3595143
    [TBL] [Abstract][Full Text] [Related]  

  • 52. No influence of proinsulin and insulin on plasma levels of plasminogen activator inhibitor type 1 and tissue plasminogen activator in young women before and during intake of contraceptive steroids.
    Petersen KR; Kjems LL; Skouby SO; Andersen LF; Jespersen J
    Metabolism; 1996 Jul; 45(7):833-7. PubMed ID: 8692017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oral contraceptive steroid induced platelet coagulant hyperactivity: dissociation of in vivo and in vitro effects.
    Huch KM; Elam MB; Chesney CM
    Thromb Res; 1987 Oct; 48(1):41-50. PubMed ID: 3424284
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term treatment of hirsutism: desogestrel compared with cyproterone acetate in oral contraceptives.
    Porcile A; Gallardo E
    Fertil Steril; 1991 May; 55(5):877-81. PubMed ID: 1827074
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exogenous progestins and breast cancer.
    Stanford JL; Thomas DB
    Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Menstrual impact of contraception.
    Stubblefield PG
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1513-22. PubMed ID: 8178900
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vitamin B6 requirements of women using oral contraceptives.
    Leklem JE; Brown RR; Rose DP; Linkswiler HM
    Am J Clin Nutr; 1975 May; 28(5):535-41. PubMed ID: 1130311
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins.
    Crook D; Godsland IF; Wynn V
    Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1612-20. PubMed ID: 3287933
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.
    Song S; Chen JK; Yang PJ; He ML; Li LM; Fan BC; Rekers H; Fotherby K
    Contraception; 1992 Jun; 45(6):523-32. PubMed ID: 1535580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.